Friday, May 1, 2026

Celltrion’s CT-P55: What Changes to FDA Clinical Trials Mean for Biosimilarity with Cosentyx?

Celltrion has applied to the FDA for changes to its Phase 3 trial of CT-P55, reducing participants to 153 to assess biosimilarity to Cosentyx.

“DON’T LEAVE US, BUT PLEASE GO” The Sick Irony of Kim Begging for U.S. Withdrawal While Terrified of Their Speed

North Korea views U.S. strategic flexibility as a threat, fearing increased military presence rather than a security gap for South Korea.

South Korea Moves to Buy 11,000 Tons of Local Citrus as U.S. Mandarins Go Tariff-Free

Jeju's Citrus Commission launches a 10,000-ton procurement program to counter U.S. mandarin imports and safeguard local farmers.

Tag: designer

No posts to display

Top News

- Our Sponsors Ad -

Follow us